Search results for "ferritin"

showing 4 items of 114 documents

Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification

2021

Abstract Objectives To stratify adult-onset Still’s disease (AOSD) patients in distinct clinical subsets to be differently managed, by using a multi-dimensional characterization. Methods AOSD patients were evaluated by using a hierarchical unsupervised cluster analysis comprising age, laboratory markers systemic score and outcomes. The squared Euclidean distances between each pair of patients were calculated and put into a distance matrix, which served as the input clustering algorithm. Derived clusters were descriptively analysed for any possible difference. Results Four AOSD patients clusters were identified. Disease onset in cluster 1 was characterized by fever (100%), skin rash (92%) an…

myalgiaAdultmedicine.medical_specialtyAdult-onset Still's diseaseFeverprecision medicineArthritisAdult-onset Still's diseaseGastroenterologyRheumatologyInternal medicinemedicineSore throatHumansPharmacology (medical)Adult-onset Still’s diseasebiologybusiness.industryMortality rateArthritisExanthemaMiddle Agedmedicine.diseaseRashFerritinC-Reactive ProteinAdult-onset Still’s disease; precision medicineFerritinsMulti dimensionalbiology.proteinmedicine.symptombusinessStill's Disease Adult-OnsetAlgorithmsBiomarkers
researchProduct

Ferritin-Coated SPIONs as New Cancer Cell Targeted Magnetic Nanocarrier

2023

Superparamagnetic iron oxide nanoparticles (SPIONs) may act as an excellent theragnostic tool if properly coated and stabilized in a biological environment, even more, if they have targeting properties towards a specific cellular target. Humanized Archaeoglobus fulgidus Ferritin (HumAfFt) is an engineered ferritin characterized by the peculiar salt-triggered assembly-disassembly of the hyperthermophile Archaeoglobus fulgidus ferritin and is successfully endowed with the human H homopolymer recognition sequence by the transferrin receptor (TfR1 or CD71), overexpressed in many cancer cells in response to the increased demand of iron. For this reason, HumAfFt was successfully used in this stud…

nanoparticleferritinOrganic ChemistrySPIONcoatingPharmaceutical ScienceSPIONs; cancer cell targeting; coating; ferritin; nanoparticlesAnalytical Chemistrycancer cell targetingSPIONsChemistry (miscellaneous)Drug DiscoveryMolecular MedicinenanoparticlesPhysical and Theoretical ChemistryMolecules
researchProduct

Optimization of the Red Tilapia (Oreochromis spp.) Viscera Hydrolysis for Obtaining Iron-Binding Peptides and Evaluation of In Vitro Iron Bioavailabi…

2020

Iron deficiencies continue to cause significant health problems in vulnerable populations. A good strategy to combat mineral deficiency includes fortification with iron-binding peptides. This research aims to determine the optimal conditions to hydrolyze red tilapia viscera (RTV) using Alcalase 2.4 L and recovery of iron-binding protein hydrolysate. The result showed that under the optimal hydrolysis condition including pH 10, 60 &deg

protein hydrolysisHealth (social science)food.ingredientHydrolyzed proteinsurface response designMineral deficiencyPlant Sciencelcsh:Chemical technologyHealth Professions (miscellaneous)MicrobiologyArticleAlcalaseHydrolysateHydrolysisfoodmedicinelcsh:TP1-1185Food scienceCaco-2 cellsbiologyChemistryTilapiamedicine.diseasebiology.organism_classificationBioavailabilityFerritinOreochromisbiology.proteiniron bioavailabilityiron-binding activityFood ScienceFoods
researchProduct

Intravenous iron therapy in patients with heart failure. A double-edged sword

2013

We read with interest the article of Beck-da-Silva et al., who recently concluded that intravenous (IV) iron seems to be superior over oral supplementation for improving functional capacity of heart failure patients [1]. Irrespective of the study design, involving comparison of functional outcomes between two different means of iron supplementation, we raise some clinical issues about the rationale underlying this investigation. According to the data published by Beck-da-Silva et al., the modest number of patients (n = 23) enrolled in this multicenter investigation had moderate anemia (i.e., hemoglobin concentration comprised between 90 and 120 g/L) but no evidence of iron deficiency, which…

therapymedicine.medical_specialtybiologymedicine.diagnostic_testbusiness.industryAnemiaCardiomyopathyheart failuremedicine.diseaseGastroenterologyFerritinRed blood celliron; therapy; heart failureironmedicine.anatomical_structureIron-deficiency anemiaInternal medicineHeart failurebiology.proteinCardiologyMedicineHemoglobinCardiology and Cardiovascular MedicinebusinessMean corpuscular volumeInternational Journal of Cardiology
researchProduct